Earnings Reportpositive
Earnings Report
Other upcoming events for NTLA
Phase 3 ReadoutPhase 3 Topline: HAELO: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the
Phase 3 ReadoutPhase 3 Topline: MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Phase 3 ReadoutPhase 3 Topline: MAGNITUDE-2: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluat
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.